Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study
- Supplementary File 1:
DOCX-Document (DOCX, 1007 KiB)
- Supplementary File 2:
ZIP-Document (ZIP, 1263 KiB)
Beugeling, M.; Amssoms, K.; Cox, F.; De Clerck, B.; Van Gulck, E.; Verwoerd, J.A.; Kraus, G.; Roymans, D.; Baert, L.; Frijlink, H.W.; Hinrichs, W.L.J. Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics 2019, 11, 510. https://doi.org/10.3390/pharmaceutics11100510
Beugeling M, Amssoms K, Cox F, De Clerck B, Van Gulck E, Verwoerd JA, Kraus G, Roymans D, Baert L, Frijlink HW, Hinrichs WLJ. Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics. 2019; 11(10):510. https://doi.org/10.3390/pharmaceutics11100510
Chicago/Turabian StyleBeugeling, Max, Katie Amssoms, Freek Cox, Ben De Clerck, Ellen Van Gulck, Jeroen A. Verwoerd, Guenter Kraus, Dirk Roymans, Lieven Baert, Henderik W. Frijlink, and Wouter L.J. Hinrichs. 2019. "Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study" Pharmaceutics 11, no. 10: 510. https://doi.org/10.3390/pharmaceutics11100510